《盈警響號》美瑞健康國際(02327.HK)料去年轉虧蝕至少1,700萬元
美瑞健康國際(02327.HK)發盈警,料去年全年錄得股東應佔虧損1,700萬元至2,800萬元,對比2018年同期則錄得純利8,050萬元。
公司表示,轉虧主要由於商譽減值增加,因去年香港社會運動致公司旗下法國巴黎醫療診所香港店收入下降,該店利潤亦大幅下降。另外期間亦確認聯營公司雲南漢素投資的減值,由於中美貿易摩擦及大麻二酚在國際上的價格大幅下滑,雲南漢素積極開拓中國市場及相關專利技術的研發和銷售,但銷往海外的大麻二酚減少,導致其經營性財務表現不佳。基於謹慎原則,對該投資中無形資產進行全額減值。公司之投資物業之公平值收益亦大幅下降,主要原因是因新型冠狀病毒肺炎爆發導致中國經濟增長放緩,及香港經濟受到抗議活動的打擊後萎縮。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.